Literature DB >> 6776531

Active site amino acid sequence of human factor D.

A E Davis.   

Abstract

Factor D was isolated from human plasma by chromatography on CM-Sephadex C50, Sephadex G-75, and hydroxylapatite. Digestion of reduced, S-carboxymethylated factor D with cyanogen bromide resulted in three peptides which were isolated by chromatography on Sephadex G-75 (superfine) equilibrated in 20% formic acid. NH2-Terminal sequences were determined by automated Edman degradation with a Beckman 890C sequencer using a 0.1 M Quadrol program. The smallest peptide (CNBr III) consisted of the NH2-terminal 14 amino acids. The other two peptides had molecular weights of 17,000 (CNBr I) and 7000 (CNBr II). Overlap of the NH2-terminal sequence of factor D with the NH2-terminal sequence of CNBr I established the order of the peptides. The NH2-terminal 53 residues of factor D are somewhat more homologous with the group-specific protease of rat intestine than with other serine proteases. The NH2-terminal sequence of CNBr II revealed the active site serine of factor D. The typical serine protease active site sequence (Gly-Asp-Ser-Gly-Gly-Pro was found at residues 12-17. The region surrounding the active site serine does not appear to be more highly homologous with any one of the other serine proteases. The structural data obtained point out the similarities between factor D and the other proteases. However, complete definition of the degree of relationship between factor D and other proteases will require determination of the remainder of the primary structure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776531      PMCID: PMC349964          DOI: 10.1073/pnas.77.8.4938

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

2.  The crystal and molecular structure of DIP-inhibited bovine trypsin at2.7Angstrom resolution.

Authors:  R M Stroud; L M Kay; R E Dickerson
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1972

3.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region.

Authors:  A Rühlmann; D Kukla; P Schwager; K Bartels; R Huber
Journal:  J Mol Biol       Date:  1973-07-05       Impact factor: 5.469

4.  Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).

Authors:  L G Hunsicker; S Ruddy; K F Austen
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Structure of crystalline -chymotrypsin. II. A preliminary report including a hypothesis for the activation mechanism.

Authors:  P B Sigler; D M Blow; B W Matthews; R Henderson
Journal:  J Mol Biol       Date:  1968-07-14       Impact factor: 5.469

Review 7.  Genetic aspects of the complement system.

Authors:  C A Alper; F S Rosen
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

8.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

9.  Properdin factor D: characterization of its active site and isolation of the precursor form.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

10.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  2 in total

1.  Complement-mediated enhancement of IgA-induced H2O2 release by human polymorphonuclear leucocytes.

Authors:  A Gorter; P S Hiemstra; P C Leijh; M E van der Sluys; M T van den Barselaar; L A Van Es; M R Daha
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

2.  The activation of the alternative pathway C3 convertase by human plasma kallikrein.

Authors:  R G DiScipio
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.